Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Technetium [99mTc] H7ND

Next Previous
X
Search
Drug Profile

Technetium [99mTc] H7ND

Alternative Names: PMD-12; Technetium [99mTc]-H7ND

Latest Information Update: 04 Jul 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jiaxing Pharmadax Genesis Pharmaceutical Technology; Unknown
  • Developer Jiaxing Pharmadax Genesis Pharmaceutical Technology
  • Class Antineoplastics; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Solid tumours

Most Recent Events

  • 05 Jun 2024 Preclinical trials in Solid tumours (Diagnosis) in China (IV), prior to June 2024
  • 05 Jun 2024 Jiaxing Pharmadax Genesis Pharmaceutical Technology plans a phase I trial for Solid tumours (Diagnosis) (IV), in May 2024(NCT06443710)
  • 14 May 2024 Phase-I clinical trials in Solid tumours (Diagnosis) in China (IV) (NCT06443710)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top